TSPAN1

TSPAN1 is a tetraspanin transmembrane protein that acts as a membrane-associated scaffold linking it to autophagy, transporter stabilization, and oncogenic signaling (PMID:32972302, PMID:21836059). Its best-defined molecular activity is in autophagy: TSPAN1 directly binds LC3 through two conserved LIR motifs, and mutation of both motifs abolishes its ability to induce autophagy and drive pancreatic cancer cell proliferation (PMID:32972302). Beyond autophagy, TSPAN1 stabilizes the thiamine transporter hTHTR-1, roughly doubling its protein half-life and increasing thiamine uptake in intestinal epithelium (PMID:21836059). In cancer it functions largely as a signaling adaptor: it promotes migration and invasion by activating PLCγ to upregulate MMP2 (PMID:30720116), epigenetically upregulates ITGA2 by modulating TET2/DNMT3B/DNMT1 to hypomethylate the ITGA2 promoter, an axis required for its pro-proliferative and pro-invasive effects (PMID:32368389, PMID:36187230), and transcriptionally activates a FAM110A/HIST1H2BK/G9a oncogenic pathway (PMID:35154458). TSPAN1 also engages specific protein partners with context-dependent outputs, binding IKBB to restrain NF-κB signaling (PMID:38135697), binding AGR2 to drive ER stress (PMID:34212407), and associating with TM4SF1 to support glioblastoma stem cell self-renewal (PMID:39060768). Upstream, TSPAN1 transcription is driven by WNT-CTNNB1 signaling via TCF/LEF elements in its promoter (PMID:32972302) and its mRNA is suppressed by ALKBH5-mediated m6A demethylation (PMID:38273746).

1. 2007 Low

   Established the first subcellular localization of TSPAN1, placing it in the cytoplasm near the Golgi rather than diffusely, providing a structural starting point for its membrane scaffolding role.

   Evidence Fluorescent immunocytochemistry and confocal microscopy in hepatocellular carcinoma cells

   PMID:18478931

   Open questions at the time

   • Single lab descriptive localization with no functional consequence linked
   • Does not establish plasma-membrane versus organelle topology
2. 2011 High

   Answered whether TSPAN1 has a physiological binding partner by showing it directly interacts with and stabilizes the thiamine transporter hTHTR-1, establishing a non-cancer scaffolding/chaperone function.

   Evidence Bacterial two-hybrid, Co-IP, GST pulldown, cycloheximide chase, and thiamine uptake assays in intestinal epithelial cells

   PMID:21836059

   Open questions at the time

   • Structural basis of the interaction not resolved
   • Whether stabilization is general to other membrane partners untested
3. 2016 Low

   Began placing TSPAN1 in growth signaling by linking its loss to increased Akt phosphorylation and G1/S transition in prostate cancer, framing it as a possible negative PI3K/Akt regulator.

   Evidence siRNA knockdown, pAkt western blot, and flow cytometry cell cycle analysis

   PMID:27556508

   Open questions at the time

   • Pathway placement inferred from phosphorylation changes only
   • No direct mechanistic link to PI3K/Akt components
   • Direction conflicts with later contexts
4. 2017 Medium

   Connected TSPAN1 to hormone-driven tumor biology by showing androgens acutely induce it and that it drives migration and mesenchymal marker expression.

   Evidence Stable overexpression, wound-healing assay, and western blot for SLUG and ARF6 in prostate cancer lines

   PMID:28701765

   Open questions at the time

   • Mechanism linking TSPAN1 to SLUG/ARF6 not defined
   • Single lab gain-of-function
5. 2019 Medium

   Defined a concrete pro-invasive mechanism by placing TSPAN1 upstream of PLCγ phosphorylation and MMP2 induction.

   Evidence siRNA knockdown/overexpression, transwell assays, and PLCγ siRNA epistasis in pancreatic cancer

   PMID:30720116

   Open questions at the time

   • How TSPAN1 triggers PLCγ translocation/phosphorylation unknown
   • No direct TSPAN1–PLCγ binding shown
6. 2020 High

   Identified TSPAN1's core molecular activity — direct LIR-dependent LC3 binding driving autophagy flux — and showed WNT-CTNNB1 signaling transcriptionally controls its expression.

   Evidence Co-IP, GFP-LC3 puncta, LIR mutagenesis, zebrafish mutant, luciferase reporter and ChIP

   PMID:32972302

   Open questions at the time

   • How a transmembrane tetraspanin presents LIR motifs to cytosolic LC3 not structurally resolved
   • FAM83A/WNT regulation from single lab
7. 2020 Medium

   Established an epigenetic effector arm by showing TSPAN1 controls ITGA2 promoter methylation via TET2/DNMT3B/DNMT1 and that ITGA2 is required for TSPAN1's oncogenic effects.

   Evidence RNA-Seq, methylation analysis, and ITGA2 knockdown rescue in pancreatic cancer (replicated in ovarian cancer, 2022)

   PMID:32368389 PMID:36187230

   Open questions at the time

   • How a membrane protein modulates nuclear TET/DNMT levels mechanistically unexplained
   • Direct versus indirect regulation unresolved
8. 2021 Medium

   Expanded TSPAN1's partner repertoire and signaling reach by identifying AGR2 binding driving ER stress, and implicating SRC and PI3K/Akt/EMT cascades downstream.

   Evidence Co-IP/IP, AGR2 rescue, pSRC and pAkt/EMT western blots, and xenografts across pancreatic, HNSCC and breast models

   PMID:33167355 PMID:34212407 PMID:34852709

   Open questions at the time

   • PI3K/Akt placement inferred from phosphorylation only (Low-confidence)
   • Conflicting positive versus negative effects on Akt across contexts unreconciled
9. 2023 Medium

   Demonstrated a tumor-suppressive partner interaction by showing TSPAN1 binds IKBB to restrain NF-κB and inhibit nasopharyngeal carcinoma metastasis, indicating context-dependent function.

   Evidence Co-IP, overexpression/knockdown, and in vitro/in vivo metastasis assays

   PMID:38135697

   Open questions at the time

   • Reciprocal validation of TSPAN1–IKBB binding limited
   • Reconciliation with pro-invasive roles in other cancers not addressed
10. 2024 Medium

    Added an upstream m6A regulatory layer (ALKBH5 demethylation suppresses TSPAN1) and a stem-cell partner (TM4SF1 in glioblastoma), broadening TSPAN1's regulatory and interaction map.

    Evidence MeRIP-qPCR with rescue, and Co-IP/IF with docking and rescue in glioblastoma stem cells

    PMID:38273746 PMID:39060768

    Open questions at the time

    • m6A reader linking demethylation to TSPAN1 stability/translation unidentified
    • Functional consequence of TSPAN1–TM4SF1 complex on signaling undefined

• It remains unknown how a single tetraspanin reconciles its opposing tumor-promoting and tumor-suppressive roles, and what structural feature of TSPAN1 coordinates membrane partners with cytosolic autophagy and nuclear epigenetic outputs.
• No structural model of TSPAN1 in its complexes
• No unifying mechanism explaining context-dependent oncogenic versus suppressive activity
• Membrane-to-nucleus signaling route undefined